Beigene Ltd
HKEX:6160

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
HKEX:6160
Watchlist
Price: 106.1 HKD 1.34% Market Closed
Market Cap: 144.6B HKD
Have any thoughts about
Beigene Ltd?
Write Note

Relative Value

The Relative Value of one Beigene Ltd stock under the Base Case scenario is 284.56 HKD. Compared to the current market price of 106.1 HKD, Beigene Ltd is Undervalued by 63%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
284.56 HKD
Undervaluation 63%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
58
Median 3Y
12.9
Median 5Y
7.6
Industry
7.6
Forward
5.2
vs History
vs Industry
Median 3Y
-14.4
Median 5Y
-20.3
Industry
22.1
Forward
-33.9
vs History
vs Industry
Median 3Y
-17.5
Median 5Y
-23.4
Industry
21.9
vs History
vs Industry
Median 3Y
-13.9
Median 5Y
-17.7
Industry
23.4
vs History
25
vs Industry
19
Median 3Y
5.1
Median 5Y
4.4
Industry
2.5
vs History
61
vs Industry
52
Median 3Y
11.3
Median 5Y
6.9
Industry
7.5
Forward
4.8
vs History
61
vs Industry
48
Median 3Y
13.7
Median 5Y
8.1
Industry
9.3
vs History
vs Industry
23
Median 3Y
-12.7
Median 5Y
-14.5
Industry
4.2
Forward
-31.6
vs History
vs Industry
21
Median 3Y
-12.7
Median 5Y
-14.5
Industry
4
Forward
-25.8
vs History
vs Industry
23
Median 3Y
-15.4
Median 5Y
-20.4
Industry
5.9
vs History
vs Industry
22
Median 3Y
-10.7
Median 5Y
-14.5
Industry
3.9
vs History
46
vs Industry
27
Median 3Y
8
Median 5Y
6.2
Industry
4.5

Multiples Across Competitors

Competitors Multiples
Beigene Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beigene Ltd
HKEX:6160
146.3B HKD 5.8 -21 -19.4 -19.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 027 714.7 -180 740.1 -219 476 -216 971.5
US
Abbvie Inc
NYSE:ABBV
310.2B USD 5.6 61 15.2 23.4
US
Amgen Inc
NASDAQ:AMGN
142B USD 4.4 33.4 16.1 30.5
US
Gilead Sciences Inc
NASDAQ:GILD
115B USD 4.1 910 10.1 10.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
101.6B USD 9.5 -211.2 20.8 21.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 852.6 -472.7 -514.8 -501.1
AU
CSL Ltd
ASX:CSL
134.4B AUD 5.7 31.8 19.7 24.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD 5.6 16.8 15.3 17
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.8 -53
NL
argenx SE
XBRU:ARGX
36B EUR 19.3 -135.6 -109.5 -79.8
P/S Multiple
Revenue Growth P/S to Growth
CN
Beigene Ltd
HKEX:6160
Average P/S: 3 457 240.5
5.8
122%
0
FR
Pharnext SCA
OTC:PNEXF
38 027 714.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.5
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.3
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
CN
Beigene Ltd
HKEX:6160
Average P/E: 210.6
Negative Multiple: -21
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 740.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.4
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
910
77%
11.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -211.2
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.7 N/A N/A
AU
CSL Ltd
ASX:CSL
31.8
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -135.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Beigene Ltd
HKEX:6160
Average EV/EBITDA: 16.2
Negative Multiple: -19.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 476 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16.1
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
20.8
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.8 N/A N/A
AU
CSL Ltd
ASX:CSL
19.7
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.3
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.8 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -109.5 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Beigene Ltd
HKEX:6160
Average EV/EBIT: 21.3
Negative Multiple: -19.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 971.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.5
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.9
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.1 N/A N/A
AU
CSL Ltd
ASX:CSL
24.6
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -79.8 N/A N/A

See Also

Discover More
Back to Top